Hengdong Shengwu

Zhongshan, China · Founded 2021 · Privately Held (backing)

Developer of agonist antibody drugs intended for tumour targeting. Hengdong Shengwu is based in Zhongshan, China and was founded in 2021.

Last price · $/share
—
Implied valuation
—
Total raised
—
Last round
—

Who backs Hengdong Shengwu?

3 investors
InvestorType
Tengye VenturesOther
Zhongshan Health Base GroupOther
Zhongshan Torch Electronic Industry Fund Management—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Hengdong Shengwu investors

3 investors are on record for Hengdong Shengwu, including Tengye Ventures, Zhongshan Health Base Group and Zhongshan Torch Electronic Industry Fund Management.

Free account
More of Hengdong Shengwu with a free account
  • ·Watch Hengdong Shengwu: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 3 firms already write checks for companies like Hengdong Shengwu. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View